松本洋的文章评论 - Suppr | 超能文献

Comment of article by Matsumoto Y.

作者信息

Campa Claudio, D'Angelo Sergio, Incorvaia Carlo

出版信息

Retina. 2008 May;28(5):782; author reply 782-3. doi: 10.1097/IAE.0b013e31816a559a.

DOI:10.1097/IAE.0b013e31816a559a

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comment of article by Matsumoto Y.松本洋的文章评论

Retina. 2008 May;28(5):782; author reply 782-3. doi: 10.1097/IAE.0b013e31816a559a.

2

Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease.贝伐单抗（阿瓦斯汀）治疗视网膜静脉阻塞疾病后出现的黄斑水肿反弹。

Retina. 2007 Apr-May;27(4):426-31. doi: 10.1097/IAE.0b013e31804a7af2.

3

Intravitreal bevacizumab for branch retinal vein occlusion.玻璃体内注射贝伐单抗治疗视网膜分支静脉阻塞。

Acta Ophthalmol Scand. 2007 Feb;85(1):118-9. doi: 10.1111/j.1600-0420.2006.00850.x.

4

Bevacizumab and macular edema.贝伐单抗与黄斑水肿。

Ophthalmology. 2008 Mar;115(3):585. doi: 10.1016/j.ophtha.2007.10.017.

5

Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗视网膜中央静脉阻塞和半侧视网膜中央静脉阻塞：IBeVO研究

Retina. 2007 Feb;27(2):141-9. doi: 10.1097/IAE.0b013e31802eff83.

6

Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.玻璃体内注射贝伐单抗治疗视网膜静脉阻塞继发黄斑水肿后的视网膜敏感性

Retina. 2009 Jun;29(6):757-67. doi: 10.1097/IAE.0b013e31819d4fbf.

7

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.前瞻性研究曲安奈德与贝伐单抗治疗视网膜中央静脉阻塞继发黄斑水肿。

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

8

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗视网膜分支静脉阻塞继发的黄斑水肿。

Retina. 2007 Apr-May;27(4):419-25. doi: 10.1097/IAE.0b013e318030e77e.

9

Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes.抗血管内皮生长因子治疗视网膜静脉阻塞所致黄斑水肿：两年观察结果。

Ophthalmology. 2010 Dec;117(12):2387-2394.e1-5. doi: 10.1016/j.ophtha.2010.03.060. Epub 2010 Jul 13.

10

Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.玻璃体内贝伐单抗与大分支和黄斑分支视网膜静脉阻塞的细胞因子水平。

Ophthalmologica. 2011;225(3):150-4. doi: 10.1159/000322364. Epub 2010 Dec 9.

引用本文的文献

1

Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model.贝伐珠单抗静脉给药后血浆 VEGF 的增加可以通过药代动力学模型预测。

Cancer Res. 2010 Dec 1;70(23):9886-94. doi: 10.1158/0008-5472.CAN-10-1419. Epub 2010 Nov 30.